The β‐adrenergic hypothesis of synaptic and microglial impairment in Alzheimer's disease

S Li - Journal of Neurochemistry, 2023 - Wiley Online Library
Alzheimer's disease (AD) is a progressive neurodegenerative disease originating partly from
amyloid β protein‐induced synaptic failure. As damaging of noradrenergic neurons in the …

Neuroprotective actions of norepinephrine in neurological diseases

M Ghasemi, N Mehranfard - Pflügers Archiv-European Journal of …, 2024 - Springer
Precise control of norepinephrine (NE) levels and NE-receptor interaction is crucial for
proper function of the brain. Much evidence for this view comes from experimental studies …

Aerobic exercise attenuates autophagy-lysosomal flux deficits by ADRB2/β2-adrenergic receptor-mediated V-ATPase assembly factor VMA21 signaling in APP …

JJ Wu, H Yu, SG Bi, ZX Wang, J Gong, YM Mao… - Autophagy, 2024 - Taylor & Francis
Growing evidence suggests that macroautophagy/autophagy-lysosomal pathway deficits
contribute to the accumulation of amyloid-β (Aβ) in Alzheimer disease (AD). Aerobic …

Activation of β2-adrenergic receptors prevents AD-type synaptotoxicity via epigenetic mechanisms

M Jin, Z Wei, N Ramalingam, M Xiao, A Xu, X Yu… - Mol Psychiatry …, 2023 - nature.com
We previously reported that prolonged exposure to an enriched environment (EE) enhances
hippocampal synaptic plasticity, with one of the significant mechanistic pathways being …

[HTML][HTML] Impact of noradrenergic inhibition on neuroinflammation and pathophysiology in mouse models of Alzheimer's disease

AK Evans, HH Park, CE Woods… - Journal of …, 2024 - pmc.ncbi.nlm.nih.gov
Norepinephrine (NE) modulates cognitive function, arousal, attention, and responses to
novelty and stress, and it also regulates neuroinflammation. We previously demonstrated …